CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Obagi Medical Products, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Obagi Medical Products, Inc.
50 Technology Drive
Phone: (562) 628-1007p:562 628-1007 Irvine, CA  92618  United States Fax: (562) 628-1008f:562 628-1008

This company ceased filing statements with the SEC on 5/6/2013.
This company is no longer actively traded on any major stock exchange.

Business Summary
Obagi Medical Products, Inc. (Obagi) is a specialty pharmaceutical company that develops, markets and sells, and is a provider of, topical aesthetic and therapeutic prescription-strength skin care systems and related products in the physician-dispensed market. Obagi systems and products are designed to prevent and improve the common and visible skin disorders in adult skin, including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, facial redness, and soft tissue deficits, such as fine lines and wrinkles. On 11/10/2017, Haitong International Zhonghua Finance Acquisition Fund I, L.P. acquired Obagi Medical Products, Inc. from Valeant Pharmaceuticals International, Inc.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/201212/31/2012YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Chief Executive Officer, Director J. MichaelPearson 53 4/25/2013 4/25/2013
Treasurer, Director Howard B.Schiller 4/25/2013 4/25/2013
Secretary, Director Robert R.Chai-Onn 42 4/25/2013 4/25/2013

General Information
Stock Exchange: NASD
Federal Tax Id: 223904668
Fax Number: (562) 628-1008


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023